AstraZeneca PLC (AZN) (AZN) |
|
44.66 0.81 (1.85%)
|
04-09 16:02 |
|
Open: |
43.91 |
Pre. Close: |
43.85 |
|
High:
|
44.98 |
Low:
|
43.5 |
|
Volume:
|
5,595,858 |
Market Cap:
|
119545M |
|
|
|
|
AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer, immunology, and neuroscience. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
45.035 - 45.202 |
45.202 - 45.337 |
|
Low:
|
43.053 - 43.262 |
43.262 - 43.429 |
|
Close:
|
44.333 - 44.659 |
44.659 - 44.921 |
|
Technical analysis |
as of: 2020-04-09 4:28:04 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 55.64  One year: 64.99 |
| Support: |
Support1: 40.54 Support2: 36.15 |
| Resistance: |
Resistance1: 47.64 Resistance2: 55.64 |
| Pivot: |
42.73 |
| Moving Average: |
MA(5): 43.98 MA(20): 42.07
MA(100): 47.34 MA(250): 44.31 |
| MACD: |
MACD(12,26): -0.20 Signal(9): -0.69 |
| Stochastic oscillator: |
%K(14,3): 82.36 %D(3): 81.87 |
| RSI: |
RSI(14): 53.28 |
| 52-week: |
High: 51.55 Low: 36.15 Change(%): 13.0 |
| Average Vol(K): |
3-Month: 466713 10-Days: 582654 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.AZN has closed below upper band by 24.6%. Bollinger Bands are 67.5% wider than normal. The large width of the bands suggest high volatility as compared to AZN's normal range. The bands have been in this wide range for 30 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
2020-04-09
Clovis Oncology Analyst Turns Bearish Ahead Of PDUFA Date For Rubraca
Despite optimistic expectations concerning label expansion for Clovis Oncology Inc's (NASDAQ: CLVS ) Rubraca to include prostate cancer, an analyst at BofA Securities is turning bearish on the stock. The Clovis Analyst Tazeen Ahmad downgraded Clovis shares from Neutral to Underperform but maintained a $6 price target. The Clovis Thesis The recent run in Clovis shares indicates a high likelihood of the FDA approving Rubraca in second line BRCA+ metastatic castration-resistance prostate cancer, or mCRPC, by the May 15 PDUFA date, Ahmad said in a Thursday note. (See the analyst's track record here .) AstraZeneca plc's (NYSE: AZN ) competing PARP … Full story available on Benzinga.com
2020-04-08
Collaboration with AstraZeneca, GSK and University of Cambridge to support UK national effort to increase COVID-19 testing - Vox Markets
Novacyt, an international specialist in clinical diagnostics, announces that as part of the UK Government’ s announcement of a new five pillar plan to increase testing for COVID-19, Novacyt is collaborating with AstraZeneca, GSK and the University of Cambridge to take action to support this national effort. A new testing laboratory will be set up by…
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: New York Stock Exchange |
| Sector: Healthcare |
| Industry: Drug Manufacturers - Major |
| Shares Out. (M) |
2620.00 |
| Shares Float (M) |
2620.00 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
18.36 |
|
Shares Short (K)
|
7840 |
|
Shares Short P. Month (K)
|
6820 |
Stock Financials |
|
EPS
|
0.510 |
|
Book Value (p.s.)
|
5.000 |
|
PEG Ratio
|
1.58 |
|
Profit Margin
|
5.47 |
|
Operating Margin
|
12.82 |
|
Return on Assets (ttm)
|
3.2 |
|
Return on Equity (ttm)
|
8.6 |
|
Qtrly Rev. Growth
|
3.8 |
|
Gross Profit (p.s.)
|
7.458 |
|
Sales Per Share
|
9.305 |
|
EBITDA (p.s.)
|
2.156 |
|
Qtrly Earnings Growth
|
-69.70 |
|
Operating Cash Flow (M)
|
2970.00 |
|
Levered Free Cash Flow (M)
|
6260.00 |
Stock Valuations |
|
P/E
|
87.55 |
|
P/E Growth Ratio
|
0.02 |
|
P/BV
|
8.93 |
|
P/S
|
|
|
P/CF
|
39.39 |
Dividends & Splits |
|
Dividend
|
2.800 |
|
Dividend Yield
|
0.06 |
|
Dividend Pay Date
|
2020-03-29 |
|
Ex-Dividend Date
|
2020-02-26 |
|
Forward Dividend
|
1.400 |
|
Last Split Date
|
2015-07-26 |
|
Last Split Ratio
|
2 |
|
7 Binary Options
|
|
Your Ad Here
|
|
